Parathyroid Auto-transplantation: Prospective Randomized Trial of the Personalized Site
- Conditions
- Parathyroid Autologous Transplantation
- Registration Number
- NCT02906748
- Lead Sponsor
- Tongji Hospital
- Brief Summary
The functional parathyroid auto-transplantation (PA) could release parathyroid hormone (PTH) into the circulatory system of the body through the capillaries. But when parathyroid glands were auto-grafted in the sternocleidomastoid muscle, it would be inconvenient to detect PTH to examine whether the graft functions. So the investigators took the forearm as the aim place for auto-transplantation, either subcutaneous or brachioradialis, with its relatively fixed - antecubital vein blood test which is simple. The survival criteria is assumed as the PTH gradient of 1.5 times or greater through comparing the bilateral PTH value in grafted and not-grafted forearm.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 280
- patients with indications for PA treatment during cervical surgery
- patients suffering secondary hypoparathyroidism with forearm fistulization
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method parahthyroid hormone gradient by comparing between grafted and non-grafted forearm 1 months, 3 months and 6 months The survival criteria is that the gradient of parathyroid hormone reaches 1.5 time or greater by comparing between grafted and non-grafted forearm
- Secondary Outcome Measures
Name Time Method hypoparathyroidism: parathyroid hormone less than 15pg/ml(range from 15 to 65pg/ml) 6 months
Trial Locations
- Locations (1)
Tongji Hospital
🇨🇳Wuhan, Hubei, China
Tongji Hospital🇨🇳Wuhan, Hubei, ChinaGaosong Wu, PhDContact0086-138-7144-4606wugaosongtj@163.com